Literature DB >> 1371812

Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural RNA.

A Hübner1, M Kruhoffer, F Grosse, G Krauss.   

Abstract

The in vitro fidelity of reverse transcriptase from human immunodeficiency virus type I (HIV-1 RT) upon copying an RNA template was measured using the phi Xam 16 reversion assay. A phi X174 sequence harboring the amber 16 codon was cloned into a transcription vector. RNA obtained from transcription by bacteriophage T7 RNA polymerase was used as a template for RNA-directed DNA synthesis by HIV-1 RT. An imbalance of dNTP concentrations during the reverse transcription step served to distinguish between errors that arose from the transcription step and errors from reverse transcription. The frequency of dGTP.U mismatches was determined to be 1/360, while dGTP.rA mismatches formed at a rate of 1/4600. These are 20-fold and sevenfold higher, respectively, than the error rates determined for the same sequence with a DNA template. Due to a high background of errors in the RNA template originating from the transcription step only upper limits for the frequency of three other mismatches can be given. The data indicate that the reverse transcription step of the HIV-1 replication cycle contributes significantly to the generation of mutant viruses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371812     DOI: 10.1016/0022-2836(92)90975-p

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  Probing the active site steric flexibility of HIV-1 reverse transcriptase: different constraints for DNA- versus RNA-templated synthesis.

Authors:  Adam P Silverman; Scott J Garforth; Vinayaka R Prasad; Eric T Kool
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

2.  Differences in mutagenesis during minus strand, plus strand and strand transfer (recombination) synthesis of the HIV-1 gene in vitro.

Authors:  W Wu; C Palaniappan; R A Bambara; P J Fay
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

3.  Strand transfer is enhanced by mismatched nucleotides at the 3' primer terminus: a possible link between HIV reverse transcriptase fidelity and recombination.

Authors:  L Diaz; J J DeStefano
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

4.  Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication.

Authors:  T Kim; R A Mudry; C A Rexrode; V K Pathak
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.

Authors:  W Maury; S Perryman; J L Oaks; B K Seid; T Crawford; T McGuire; S Carpenter
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Cloning and expression of a human T-lymphotropic virus type 1 protein with reverse transcriptase activity.

Authors:  S M Owen; R B Lal; R A Ikeda
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  Mispair extension fidelity of human immunodeficiency virus type 1 reverse transcriptases with amino acid substitutions affecting Tyr115.

Authors:  A M Martín-Hernández; M Gutiérrez-Rivas; E Domingo; L Menéndez-Arias
Journal:  Nucleic Acids Res       Date:  1997-04-01       Impact factor: 16.971

8.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.

Authors:  J C Boyer; K Bebenek; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

Authors:  A Meyerhans; J P Vartanian; C Hultgren; U Plikat; A Karlsson; L Wang; S Eriksson; S Wain-Hobson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.